Literature DB >> 6368245

Gram-negative septicemia in patients with hematologic malignancies.

G Todeschini, F Vinante, F Benini, A Perini, F Pasini, G Cetto.   

Abstract

The clinical records of 66 consecutive episodes of Gram-negative bacteremia occurring in 60 patients with hematologic malignancies during a 66-month period were reviewed to assess the major prognostic factors. The bacteremia-related mortality was 53%. Overall, Pseudomonas aeruginosa (54%) and Escherichia coli (24%) were the predominant isolates (fatality rate 78 and 31% respectively). The majority of patients (58/66) were granulocytopenic (PMN less than 1000/microliters). Among the 18 patients whose circulating granulocytes increased by one log10 or to above 1000/mmc during therapy, the fatality rate was 39%, as opposed to 70% in the 40 patients without such an increase. Pneumonia-associated bacteremia (56%) had a high fatality rate (73%) compared to isolated bacteremias (27%). Septic shock and inappropriate antibiotic therapy accounted for the highest mortality. Our data suggest that Pseudomonas etiology, persistent neutropenia, associated pneumonia, septic shock and inappropriate antibiotic therapy account for a bad prognosis in Gram-negative bacteremia in hematologic malignancies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368245     DOI: 10.1016/0277-5379(84)90077-4

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  7 in total

Review 1.  Empiric treatment of infection during granulocytopenia: a comprehensive approach.

Authors:  J Klastersky
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

2.  Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.

Authors:  D R Wagner; D Heinrich
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

3.  [Septicemia in leukemia and malignant lymphoma. Incidence pathogens--causes].

Authors:  H H Hennemann
Journal:  Klin Wochenschr       Date:  1985-09-02

4.  Nosocomial septicemias due to methicillin-resistant staphylococcus aureus and Pseudomonas aeruginosa in a university hospital over a 12-year period--the same intractable infections.

Authors:  Y Mizushima; H Li; I Yoshida; K Sassa; T Hamazaki; M Kobayashi
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

5.  Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.

Authors:  D E Schiff; C A Wass; S J Cryz; A S Cross; K S Kim
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

6.  Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.

Authors:  S J Cryz; A S Cross; J C Sadoff; E Fürer
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.609

7.  Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.

Authors:  Hyo Sup Kim; Bo Kyoung Park; Seong Koo Kim; Seung Beom Han; Jae Wook Lee; Dong-Gun Lee; Nack-Gyun Chung; Bin Cho; Dae Chul Jeong; Jin Han Kang
Journal:  BMC Infect Dis       Date:  2017-07-17       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.